HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipid profile and atherogenic indices soon after birth in Japanese preterm infants.

AbstractAIM:
The intra-uterine environment affects the risk of development of cardiovascular disease in adulthood. The aim of this study was to determine the influence of prematurity and foetal growth restriction on lipid metabolism, by assessing atherogenic indices soon after birth in preterm infants.
METHODS:
Blood samples were collected within 20 min of birth from 80 preterm infants with a gestational age of ≤35 weeks. Serum total cholesterol (TC), low-density lipoprotein cholesterol (LDLc), high-density lipoprotein cholesterol (HDLc), apolipoprotein-A1 (apoA1) and apolipoprotein-B (apoB) levels were measured. The ratio of TC/HDLc, LDLc/HDLc and apoB/apoA1 were also calculated. Correlations between these indices and gestational age, birth weight and the standard deviation (SD) score for birth weight were also determined.
RESULTS:
Gestational age, birth weight and SD score for birth weight were negatively correlated with the TC/HDLc, LDLc/HDLc and apoB/apoA1 ratios.
CONCLUSION:
In preterm infants, prematurity and poor foetal growth may influence lipid and apolipoprotein metabolism and affect atherogenic indices at birth.
AuthorsHiromichi Shoji, Yayoi Murano, Mari Mori, Nobuaki Matsunaga, Natsuki Ohkawa, Hiroki Suganuma, Mitsuru Ikeno, Ken Hisata, Satoshi Hirayama, Tsuyoshi Ueno, Takashi Miida, Toshiaki Shimizu
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 103 Issue 1 Pg. 22-6 (Jan 2014) ISSN: 1651-2227 [Electronic] Norway
PMID24117869 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2013 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Chemical References
  • Apolipoproteins
Topics
  • Adult
  • Apolipoproteins (blood)
  • Female
  • Fetal Growth Retardation (metabolism)
  • Humans
  • Infant, Newborn
  • Infant, Premature (blood)
  • Lipid Metabolism
  • Male
  • Pilot Projects

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: